Market Highlights
Metabolomics Services Market is expected to register a CAGR of 7.77%% during the forecast period with a market value of USD 16,291.0 Million till 2025. Metabolomics services have been growing at a rapid pace over the last few years. Metabolomics services provide information about the metabolic phenotype by identifying and quantifying the biochemical byproducts of metabolism using different technologically advanced products. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8435 The major key factors driving the market growth are the growing prevalence of diseases such as cancer, neurological disorders, and cardiac diseases across the globe, technological advancements in instrumentation, and increasing application of metabolomics in the life science and biotechnological industry. However, factors such as high cost of instruments and stringent government policies/regulations may hamper the market growth. Segment Analysis The Global Metabolomics Services Market is segmented into product and service and application. Based on product and service, the market has been segmented into chromatography, metabolomics bioinformatics services, and mass spectrometry. On the basis of application, the global metabolomics services market has been segmented into biomedical and pharmaceutical, agriculture, and food. Regional Analysis The Global Metabolomics Services Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to hold the largest share of the global metabolomics services market. This is owing to the increasing patient population suffering from cancer, and cardiovascular diseases are boosting the market growth in this region. The Europe market holds the second-largest position in the global metabolomics services market due to the presence of a large number of companies such as Biocrates Life Sciences AG (Biocrates), Bruker, Waters, and other providing metabolomics services drives the growth of the market in this region. Asia-Pacific is estimated to be the fastest-growing region owing to a large number of patient population suffering from chronic disease and increasing demand for treatment for the same. The metabolomics services market in the Middle East & Africa accounts for the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018. Key Players MRFR recognizes the following companies as the Key Players in the Global Metabolomics Services Market--Agilent Technologies, Inc. (US), Waters (US), Bruker (US), TMIC (CANADA), Thermo Fisher Scientific (US), Biocrates Life Sciences AG (AUSTRIA), Creative Proteomics (US), Human Metabolome Technologies America Inc (JAPAN), Shimazdu Corporation (Japan), and Metabolon, INC (US) Key Findings of the Study
0 Comments
Market Highlights
According to MRFR analysis, Pain Relief Medication Market is expected to register a CAGR of 4.73% during the forecast period of 2019 to 2025 and held a value of USD 55,275 million in 2018. Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8431 The growth of the global pain relief medication market is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market. Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) for the management of moderate to severe pain associated with endometriosis. Segmentation The global pain relief medication market has been segmented based on drug class, indication, and distribution channel. The market, based on drug class, has been divided into nonsteroidal anti-inflammatory drugs, opioids, COX-2 inhibitors, and others. The nonsteroidal anti-inflammatory drug segment is likely to be the largest during the review period due to the high efficacy rate of this drug class. The opioids segment is predicted to be the fastest-growing due to the increasing awareness about the drugs in this class in the pain relief medication market. The global pain relief medication market has been segmented based on the indication, into cancer pain, neuropathic pain, musculoskeletal pain, inflammatory conditions, and others. The cancer pain segment is expected to hold the majority share of the market owing to the increasing people suffering from this type of pain. The neuropathic pain segment is expected to be the fastest-growing due to the rising patient population in different economies. The global pain relief medication market, by distribution channel, has been divided into hospital and retail pharmacies, and online pharmacies. The hospitals and retail pharmacies segment is projected to hold the largest share of the market due to the increasing number of hospital in-visits. The online pharmacies segment is expected to be the fastest growing owing to the rise in the awareness about online distribution network. Key Players Some of the key players in the global pain relief medication market are AbbVie Inc. (US), Allergan plc (Ireland), Astellas Pharma Inc. (Japan), Bayer (Germany), Biogen Idec (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb (US), Eli Lilly and Company (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Pfizer, Inc. (US), Purdue Pharma (US), Sanofi (France), and Teva Pharmaceutical Industries Ltd (Israel). Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the rise in chronic diseases in this region. In Brazil, chronic pain is a widespread clinical condition, affecting between 28% and 41% of the Brazilian population. The pain relief medication market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European pain relief medication market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pain relief medication market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rise in initiatives by public and private organizations, the market in Asia-Pacific is expected to be the fastest-growing. The pain relief medication market in the Middle East & Africa has been divided into the Middle East and Africa. FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/pain-relief-medication-market-8431 Market Highlights
The Global Perfusion Radiology Market is expected to register a CAGR of 7.48% during the forecast period, with a market value of USD 9,858 Million till 2025. Perfusion is the passage of fluid through the lymphatic system to organs or tissues. Perfusion radiology is the process by which passage of perfusion can be observed, recorded, and quantified. This is widely used for the diagnosis of chronic disorders such as cancer, brain tumor, and lung-related disorders. The growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology are expected to enhance market growth. However, the stringent regulatory policies and lack of awareness for the use of advanced technologies are projected to curb the growth of the market. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8419 Segment Analysis The Global Perfusion Radiology Market, by application, has been segmented into cardiovascular imaging, ventilation imaging, brain imaging, and others. By end-user, the global perfusion radiology market has been classified as hospitals, diagnostic centers, and others. Regional Analysis The Global Perfusion Radiology Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. North America accounted for the largest market share of in 2018, owing to the incidence of cardiovascular diseases, brain tumors, and tumor-related angiogenesis Europe is anticipated to account for the second-largest market share during the forecast period. The market growth in Europe can be attributed to the considerable rise in neurological disorders. For instance, according to the European Brain Council, 2017 data, a total of 220.7 million people in Europe were suffering from at least one neurological disease, which promoted the use of perfusion radiology for the diagnosis of such diseases. Asia-Pacific is likely to be the fastest-growing region in the global perfusion radiology market. The high growth rate is due to owing to the presence of rapidly developing economies of China, India, and South Korea. India held a share of 18.8% in the Asia-Pacific perfusion radiology market in 2018. The Middle East & Africa market is projected to show gradual growth during the forecast period. In this region, the Middle East is anticipated to dominate owing to the presence of developed countries such as Egypt, Saudi Arabia, and others. Key Players MRFR recognizes the following companies as the Key Players in the Global Perfusion Radiology Market— GE Healthcare (US), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Bracco Diagnostic, Inc. (Italy), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Lantheus Medical Imaging, Inc (US), Perimed (US), Neusoft Corporation (China), and Advantis Medical Imaging (Netherlands) Key Findings of the Study
Market Highlights
The global flat panel detector (FPD) market held a market value of USD 3.06 Billion in 2018 and is projected to grow at a CAGR of 6.7% over the forecast period. Flat panel detector (FPD) is a type of solid-state X-ray digital radiography device. It works in the same way as image sensors used in digital photography and video works. Growing public and private investments in digital imaging technologies and declining prices and benefits offered by digital detectors are positively affecting market growth. Additionally, growing medical tourism in developing countries is also expected to drive the market growth. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7903 On the other hand, the high cost of the system is likely to hamper the growth of the market. Segmentation The global flat panel detector (FPD) market has been segmented by portability, application, and end user. By portability, the market has been segmented into fixed and portable. The portable flat panel detector is expected to show the largest market share. By application, the market has been segmented into medical, orthopedic, cardiac, veterinary, mammogram, dental, and others. The market, by end user, has been segmented into hospitals and clinics, and diagnostic centers. Key Players Some of the prominent players in the global flat panel detector (FPD) market are General Electric Company, Carestream Health, Canon Medical Systems Corporation, Fujifilm Holdings America Corporation, PerkinElmer Inc., Trixell, iRay Technology, Varian Medical Systems, Inc., Agfa-Gevaert Group, New Medical Imaging Co., Ltd, Varex Imaging Corporation, Imaging Dynamics Company Ltd and others. Regional Analysis On a regional basis, the Americas is anticipated to dominate the global flat panel detector (FPD) market owing to the technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases in the region has fueled the growth of the market. Additionally, major companies are located in North America which is fueling the market growth. Europe is expected to hold the second largest position in the global flat panel detector (FPD) market owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure in the European countries. Well-developed technologies in Europe have also played a predominant role in the development of the European market. Asia-Pacific is anticipated to be the fastest growing region in the global flat panel detector (FPD) market owing to the growing adoption of digital imaging systems, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments. The Middle East & Africa has the least share of the global flat panel detector (FPD) market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector. FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/flat-panel-detector-market-7903 Market Highlights
The Global Autoinjectors Market is Estimated to be Valued at USD 79,741 Million by 2024 and is Expected to Register a CAGR of 17.42% During the Forecast Period. The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Million by the end of 2024. The increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6311 Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 18.95% during the forecast period of 2019 to 2024. Segment Analysis The Global Autoinjectors Market has been segmented on the basis of product type, design therapeutic application, distribution channel, and region. On the basis of product type, the market has been divided into the disposable autoinjectors and reusable autoinjectors. The disposable autoinjectors segment held the majority market share in 2018. It also was the fastest-growing owing to the increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors. Market Players Market Research Future (MRFR) recognizes Amgen Inc. (US), Becton, Dickinson and Company (US), AbbVie Inc. (US), Mylan N.V. (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Owen Mumford Ltd (UK), Consort Medical (UK), SHL Group (Taiwan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Antares Pharma (US) as the key players in the Global Autoinjectors Market. Regional Analysis Geographically, the global autoinjectors market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for the autoinjectors in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The well-established healthcare infrastructure, technology advancement, and innovation in drug delivery systems, and rising prevalence of anaphylaxis incidences, diabetes, and cancer are driving the growth of the autoinjectors market in the region. Germany accounted for the largest market share of 24.7% in 2018, and the country-level market is projected to register a CAGR of 15.84% during the forecast period. FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/autoinjectors-market-6311 Laparoscopy Devices Market Shares Analysis, Key Development Strategies And Forecasts Till 202312/30/2020 Market Highlights
The Global Laparoscopy Devices Market Is Estimated To Be Valued At USD 17,206.32 Million By 2023 And Expected To Grow At A CAGR Of 8.30% During The Forecast Period. Laparoscopy devices are used in surgical procedures that permit a surgeon to access the inside of the abdomen and pelvis without having to make large incisions in the skin. This laparoscopic surgical procedure is also known as keyhole surgery or minimally invasive surgery. Laparoscopy devices capture images in the stomach, small intestine, and pelvic system which are utilized for the diagnosis of various intestinal, gynecological, and urological diseases. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6312 The demand for laparoscopic surgical procedures is rising due to major benefits associated with these surgeries such as small or no incision, short hospital stays, less pain, quick recovery time, less scarring, and reduction in blood loss. Market Research Future (MRFR) recognizes the following companies as the key players in the global laparoscopy devices market that includes: Becton, Dickinson and Company (US), Smith & Nephew PLC (UK), B. Braun Melsungen AG (Germany), Medtronic PLC (US), Cook Medical LLC (US), Fujifilm Holdings Corporation (Japan), Olympus Corporation (Japan), Stryker Corporation (US), KARL STORZ SE & Co. KG (Germany), Richard Wolf GmbH (Germany), and others. Segment analysis Global laparoscopy devices market has been segmented on the basis of product, application, and end user. On the basis of product, the global laparoscopy devices market has been segmented into laparoscopes, energy devices, insufflation devices, suction/irrigation devices, handheld instruments, access devices, trocars, internal closure devices, and others. A laparoscope is a leading segment, which is growing at the highest CAGR to reach USD 5091.77 million by the end of 2023. Based on application, the global laparoscopy devices market has been segmented into general surgery, bariatric surgery, gynecological surgery, urological surgery, colorectal surgery, and others. The general surgery segment accounts for a major share with 7.79% CAGR during the forecast period. On the basis of end user, the global laparoscopy devices market has been segmented into ambulatory centers, hospitals and clinics, and specialty centers. The hospitals & clinics segment accounted for a considerable market share of 38.11% as of 2017. Regional Analysis Geographically, the global laparoscopy devices market is segmented into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, The Americas acquired the largest share in the market owing to its high GDP per capita income and the rising geriatric population which is highly prone to degenerative diseases and chronic illnesses, causing an increased need for diagnosis and therapeutics. For instance, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. For instance, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. The European market is expected to register a second largest market share during the forecast period due to major driving factors such as rising patient population of cancer, increasing research on laparoscopy advancements, availability of advanced treatment facilities, increasing healthcare expenditure, and introduction of advanced and integrated monitoring devices into the market along with the presence of a good healthcare infrastructure. Asia-Pacific is the fastest growing market for laparoscopy devices. The Asia-Pacific laparoscopy devices market is expected to reach USD 4205.58 million by the end of 2023. It is attributed to the huge patient population and rapid development in technology. Also, the government of this region is looking forward to availing better treatment options from developed nations to improve the quality of life of their citizens. The laparoscopy devices market in the Middle East and Africa is divided into two regions, namely, the Middle East and Africa. Africa holds the least share of the market due to poor political conditions in Africa and the limited availability of funds and medical facilities. FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/laparoscopy-device-market-6312 Endodontic Devices Market Shares Analysis, Key Development Strategies And Forecasts Till 202312/30/2020 Market Highlights
The global endodontic devices market is expected to register an approximate CAGR of 5.34% during forecast period, 2018–2023. Endodontics is a part of dentistry which deals with the study and treatment of the dental tissue. Endodontic treatment is also called root canal treatment which involves the diagnosis, prevention, and treatment of illnesses and injuries of the dental pulp. The development by the medical device companies in the dental care immensely improved the quality of dental treatment. The increasing globalization and adoption of new technology contribute to driving the endodontic device market. The major key factors contributing to driving this market are increasing prevalence of the dental problem, microbial infected tooth, rising aging population and increasing incidence of oral cavity cancer among the population. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7809 However, the factors such as high cost of treatment, illegal sales of dental products and complications related to treatments may hamper the market growth during the forecasted period. Segmentation The global endodontic devices market is segmented on the basis of product, end user, and region. On the basis of product, the global endodontic devices market is segmented into consumables and instruments. By consumables, the global endodontic devices market is categorized into endodontic burs, endodontic files & shaper, irrigating solution & lubricants, obturation filling materials and others. By instruments, the market is further sub-segmented into apex locators, endodontic scalers, machine-assisted obturation systems, handpieces, and endodontic lasers. By end-user, the global endodontic devices market is categorized into dental clinics, dental hospitals, laboratories, dental academic and research institutes.On the bases of region, the global endodontic devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to hold the largest market share and the Middle East & Africa with a low market share during the forecasted period. Regional Analysis The Americas dominates the global market for endodontic devices owing to the rising occurrence of dental infections because of changing eating habits, the rise in prevalence of dental ailments, and growth rate of accidents. Also, the presence of a large number of medical device companies within the region drives the market. In 2017, it was estimated that Europe stood second in the global endodontic devices market due to the rising demand for root canal treatment and increasing microbial infection in teeth in boosts the market growth. Asia-Pacific was the fastest growing region for the global endodontic devices market in 2017. Factors such as increasing innovation and awareness about the available treatment methods of various dental problems fuels the market growth within the region. On the other hand, the Middle East and Africa holds the least share in the global endodontic devices market. The presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. A majority of the market share within this region is estimated to be held by the Middle East. Key Players Some of the key players in the global endodontic devices market are DENTSPLY SIRONA, Danaher Corporation, Ivoclar Vivadent, Ultradent Products, Septodont, Brasseler USA, MICRO-MEGA, DiaDent Group International, COLTENE Holding, Kerr Corporation, Surtex Instruments Limited, Davis Schottlander & Davis Ltd, Hu-Friedy Mfg. Co., LLC, and others. FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/endodontic-devices-market-7809 Market HighlightsRabies is a life treating a viral disease which is caused by the biting of an infected rabid animal. It is fever, headache, muscle aches, loss of appetite, nausea, and tiredness to the infected animal or human. The surge in the prevalence of rabies, increasing awareness about rabies, and a rising number of pet animals are expected to drive the growth of the global rabies diagnostics market during the forecast period. Moreover, ongoing research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and new product launches by major players are also boosting the growth of the market. According to the report published by World Organization for Animal Health, Asia-Pacific region is hugely affected by rabies owing to the increasing cases of rabies, in Asia approximately 31000 deaths were caused by rabies which is 56% of the total cases.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7796 The high costs associated with the diagnostic, absence of awareness about rabies and scarcity of skilled workforce may hamper the growth of the market during the assessment period. Regional Analysis The market is likely to dominate by Asia-Pacific during the forecast period owing to the improving healthcare infrastructure, increasing investments in the healthcare sector and expansions by market players in the region. Also, a country such as India and China are considering the fastest growing region due to a government focused toward adopting new technology, and the best treatment option from a developed country. The Americas are expected to be the second-largest market in the global rabies diagnostics market due to the rising collaborative activities by major players, raising awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure. The European market is likely to hold a significant market share in the rabies diagnostics market. The government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development are responsible for the growth of this market in the region. The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Segmentation The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region. Based on method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests. Global rabies diagnostics market on the basis of technology has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others. Based on market has been segmented into hospitals, diagnostic centers, cancer palliative care clinics, and others. Key Players Some of the key players in the global rabies diagnostics market are Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote, Inc., Express Biotech International Inc., MyBioSource.com., and BioGen TechnologiesFOR MORE DETAILS – https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796 Enteral Feeding Devices Market Overview
As per Market Research Future (MRFR) analysis, the global enteral feeding devices market held a valuation of USD 2,302.4 million in 2017. It is estimated to grow at a CAGR of 6.1% from 2017 to 2023 (forecast period). Enteral feeding is a nutritional therapy process where nutrients are supplied directly to the gastrointestinal tract (GIT). It is a therapy for patients who are unable to get sufficient nutrition by eating or drinking or unable to swallow food by mouth. Enteral feeding devices help deliver medications and nutrients directly to the stomach, duodenum, or jejunum via either the nose, mouth or direct percutaneous route. Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7828 Enteral Feeding Devices Market Dynamics Market growth drivers include a rising geriatric population worldwide, along with a rising prevalence of chronic diseases, an increasing change from parenteral to enteral nutrition, and a growing incidence of preterm births. For example, the World Health Organization (WHO) stated that the global elderly population was 841.0 million in 2013, 962.3 million in 2017, and expected to reach more than 2.0 billion by 2050. On the other hand, complications associated with enteral feeding devices, including inadvertent dislodgement of tubes and strict refund policies, are expected to hinder market growth over the forecast period. Enteral Feeding Devices Market Segmentation The global market for enteral feeding devices market has been segmented into product, age group, indication, and end-user. Based on the product, the global market for enteral feeding devices has been segmented into enteral feeding pumps, enteral feeding tubes, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further segmented into nasoenteric feeding tubes, oroenteric feeding tubes, and enterostomy feeding tubes. The segment for enterostomy feeding tubes is additionally divided into gastrostomy tubes, gastrojejunostomy tubes, and jejunostomy tubes. The nasoenteric feeding tubes segment is further categorized into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The segment of enteral pumps is expected to lead the market over the forecast period due to the low risk of complications with the use of feed pumps, improved portable pump designs, and the growing use of pumps in hospitals and home care settings. Based on the age group, the global market for enteral feeding devices has been divided into adults and pediatrics. Based on indication, the global market for enteral feeding devices has been segmented into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further divided into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. Based on end-user, the global enteral feeding devices market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). Enteral Feeding Devices Market Regional Analysis Region-wise, the global enteral feeding devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas led the global market for enteral feed devices in 2017. This is due to the involvement of significant market players and well-established healthcare infrastructure, the growing prevalence of lifestyle diseases, and rising technical advancements in enteral feeding. Such market players are engaged in manufacturing technologically advanced devices, including texture modifications in products that meet individual patient requirements. The demand for disposable and portable pumps from healthcare centers and small peripheral laboratories is on the rise, thus encouraging market development. Europe is anticipated to follow Americas in terms of value owing to early product approval, market launch, and high adoption of enteral feeding pumps, as well as an increasing number of reconstructive surgeries and radiotherapy procedures in the United Kingdom, Germany, and France. The Asian Pacific market is likely to have a comparatively higher CAGR during the forecast period due to an increasing geriatric population, an expanding number of malnutrition patients and preterm births, and a growing awareness for the use of enteral feed devices. For example, the WHO estimated that there were approximately 1.71 million preterm births in China and 3.5 million preterm births in India between January 2014 and November 2015. The market for enteral feed devices in the Middle East and Africa is expected to witness moderate market growth rate between 2018 and 2023 due to the development of the healthcare sector in the Gulf Cooperation Council (GCC) countries. Enteral Feeding Devices Market Key players Some of the spearheads in the global enteral feeding devices market are Abbott Laboratories, Medtronic plc, Cook Medical, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Boston Scientific Corporation, CONMED Corporation, Moog, Inc., Nestlé, Halyard Health, Inc., and Vygon SA. Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828 Market Highlights
It is estimated that the global immunoprecipitation market is expected to hold a market value of USD 562 million and register a CAGR ~ 5.2% during the forecast period of 2018–2023. The method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein is known as immunoprecipitation. This technique can be used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. A growing number of research activities in the life sciences sector and rising need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Furthermore, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7816 However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period. The global immunoprecipitation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2018, Abcam plc entered into a strategic agreement with F. Hoffmann-La Roche Ltd, a leading biotech company, under which Abcam received the exclusive rights to the product portfolio of Spring, that consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products. Regional Analysis Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region. Europe is expected to hold the second largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research. Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics. On the other hand, the Middle East & Africa is expected to account for the least share of the market. Segmentation The global immunoprecipitation market has been segmented into type, product, end-user, and region. The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation. The market, by type, has been segmented into kit, reagent, and others. The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers. The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others. Key Players Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc. FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816 |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |